| |
|
|
|
|
|
|
|||
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
From the Faculty of Tropical Medicine, Department of
Pathobiology, Faculty of Science, and Office for Research and
Development, Faculty of Medicine, Mahidol University, Bangkok,
Thailand; and the Nuffield Department of Medicine, John Radcliffe
Hospital, Oxford University, Oxford, United Kingdom.
Hemoglobin E is very common in parts of Southeast Asia. The
possible malaria protective effects of this and other inherited hemoglobin abnormalities prevalent in Thailand were assessed in a mixed
erythrocyte invasion assay. In vitro, starting at 1% parasitemia, Plasmodium falciparum preferentially invaded normal (HbAA)
compared to abnormal hemoglobin (HbH, AE, EE, HCS, The progression to disease and sometimes death from
malaria is determined by several factors including the level of host
immunity, the innate resistance characteristics of the host, and the
virulence of the infecting parasites. Innate host resistance is
manifest by inherited red blood cell (RBC) characteristics such as the Duffy blood group determinant Fya Fyb, which
renders the RBCs resistant to invasion by Plasmodium vivax, alterations in the erythrocyte membrane as in ovalocytosis, deficiency in glucose-6-phosphate dehydrogenase, or abnormalities of hemoglobin composition as in thalassemia or sickle cell trait. In 1949, J. B. S. Haldane hypothesized that the high gene frequencies of
hemoglobinopathies in malaria-endemic areas may have resulted from
protection conferred against malaria The mechanisms underlying malaria protection by these genetic RBC
variants have been studied extensively and can be classified into
several broad groups: (1) reduced probability of merozoite invasion
into the variant RBCs, (2) impairment of parasite growth within the
variant RBCs, (3) enhanced removal of the parasitized variant RBCs, and
(4) enhanced probability of infection early in life, particularly with
P vivax, which protects against subsequent severe P
falciparum malaria.12 Nevertheless despite
considerable research, the relative roles of these processes and the
cellular mechanisms that mediate resistance of many of these genetic
RBC variants to malaria parasites remain unclear.
To evaluate the susceptibility of RBCs to invasion by malaria
parasites, the RBCs must be studied under standardized conditions ex
vivo. We have addressed the problems associated with variation in
culture conditions, and thus invasion/growth rate differences between
experiments, by cultivating different "abnormal" RBCs mixed with an
equal proportion of control cells and relating differences only to the
control values. RBC susceptibility is a major determinant of the
severity of malaria infection. We have shown recently that only one
eighth of the normal RBC population in vivo is susceptible to P
vivax infection, and that in uncomplicated P
falciparum malaria only one third to one half of the RBC
population is available for invasion, whereas in severe malaria there
is no evidence of RBC selectivity.13 Nonselective invasion
is therefore a virulence determinant associated with higher
multiplication rates at high parasite densities and resultant larger
parasite biomasses.14 In this study, possible protective
mechanisms against severe P falciparum malaria were assessed
by measuring the relative susceptibility to parasite invasion of
hemoglobinopathic RBCs compared to RBCs with a normal hemoglobin type
at high parasite densities. The studies were performed at relatively
high parasite densities designed to reflect progression to heavy
parasitemias and severe infection.
Abnormal hemoglobin RBCs
Control RBCs
Parasite culture P falciparum, 4 Thai strains, each of a single genotype (TM267R, TAB106, TAB169, and TAB183), were maintained in continuous culture in fresh normal blood group A, B, or O RBCs in RPMI 1640 medium supplemented with 10% heat-inactivated human AB+ serum and 2 µmol/L glutamine, 25 mM Hepes, and 20 µg/mL gentamicin (MCM) at 37°C, in an atmosphere of 5% CO2 using standard methods.18 Parasites were stage-synchronized by sorbitol lysis19 or Percoll gradient purification.16 The mature schizont stages, cultured at 2% parasitemia and 5% hematocrit, were used to generate merozoites for the invasion assay.Assessment of RBC susceptibility to P falciparum invasion The parasite cultures in fresh RBCs containing 2% synchronized schizont-infected RBCs at 5% hematocrit were mixed with an equal number of a 5% suspension of "abnormal hemoglobin" RBCs to give a final parasitemia of 1%. The number of cells added was based on direct RBC counts. Parasite cultures in normal A, B, or O RBCs were chosen so that the major blood group differed from that of the abnormal RBCs in the test before mixing. Cultures mixed with normal and abnormal RBCs (1:1) were kept under culture conditions for 24 hours. Thin films made at the start of cultures were stained with Field stain, and parasitemia was assessed by counting 1000 RBCs per slide. After 24 hours, the cultures were washed in RPMI 1640. The packed RBCs were then resuspended in fetal calf serum (FCS) at 50% hematocrit and thin blood films were made, fixed with absolute methanol, and dried for the immunofluorescence assay. Parasite cultures mixed with normal hemoglobin RBCs (HbAA) were used as controls. To determine whether it was necessary to agitate the parasite cultures to optimize invasion, 10 static cultures (5 normal AA and 5 with thalassemic RBCs) were conducted in parallel with agitated cultures of the same cells (3-dimensional rocking platform shaker STR9, Stuart Scientific, London, United Kingdom at a speed of 20 revolutions/min for 3 hours).Immunofluorescence assay The abnormal hemoglobin RBCs were distinguished from the normal RBCs in the cultures by immunofluorescence staining of different major blood groups as follows. Monoclonal mouse antiblood group A or B (Zymed Laboratory, no. 18006-7, San Francisco, CA; 5 µL) was placed on the demarcated area on the thin blood films, placed in a humidified chamber for 30 minutes at room temperature, then washed twice in phosphate-buffered saline. Mouse immunoglobulin Fab fragments conjugated with fluorescein isothiocyanate (Dako, no. F 0313, Glostrup, Denmark; 5 µL) were then added. After 30 minutes of incubation the slides were washed twice and mounted with 50% buffered glycerol containing 10 µg/mL ethidium bromide (EB) and examined by UV light microscopy.Selectivity of parasite invasion into the RBCs The number of fluorescent RBCs (those with abnormal hemoglobin) and unstained RBCs (those with normal hemoglobin, HbAA) in the cultures were counted for 1000 RBCs per slide. Parasites were counted in the 2 populations to a total of 1000 RBCs. Multiplication rates were determined for the individual cell types as final parasitemia divided by starting parasitemia. The susceptibility of the RBCs was expressed as a relative susceptibility ratio (SR) and the selectivity index (SI) determined.13 The SR was defined as the ratio of the number of malaria parasites in stained RBCs to that in the unstained RBCs divided by the ratio of the stained to the unstained RBCs used in starting cultures: relative susceptibility ratio (SR) = (stained infected RBCs/stained RBCs) (unstained infected
RBCs/unstained RBCs).
The SI was determined from cultures of a single parasite isolate
(TM267R) in the RBCs under investigation adjusted to 1% parasitemia as
follows. An infected RBC containing more than one ring-stage parasite
was classified as a multiply invaded cell. The number of multiply
invaded stained and unstained RBCs was counted in a total of 300 infected RBCs. The SI was defined as the ratio of the observed
proportion of multiple infected RBCs to the proportion expected from a
random process (Poisson distribution)13: selectivity index
(SI) = (the observed value of infected RBCs with multiple invasion) Statistical analysis Normally distributed data were compared using the paired t test and correlations using Pearson correlation coefficient. The relative SR of abnormal hemoglobin RBCs was compared to that of normal RBCs using the Mann-Whitney U test and Spearman correlation coefficient. The Wilcoxon signed rank test was used to test the difference between the SI and parasitemia of abnormal and normal hemoglobin RBCs within the same slide. The statistical package SPSS for windows (SPSS, Gorinchem, The Netherlands; 1998) was used for analysis. A conservative P < .01 was chosen for the level of significance.
Patients Red blood cells from 109 individuals were investigated, including 9 with HbH with Constant Spring ( -thalassemia1/CS;![]() /![]() cs), 13 with HbH disease
( -thalassemia1/ -thalassemia2;
o +;![]() /![]() ), 22 HbE homozygotes
(HbEE), 20 HbE heterozygotes (HbAE), and 45 o-thalassemia with HbE disease ( -thal/HbE; 17 of them
had had a previous splenectomy). The 109 individuals with abnormal
hemoglobin RBCs had lower values for MCV (mean (SD) = 6710 fl, and
MCH (mean (SD) = 203.6 pg compared to the normal range of the normal
RBCs (n = 34) (mean (SD) of MCV = 819 fl and mean (SD) of
MCH = 292.4 pg, P = .001. The RBC indices of
heterozygote AE subjects were MCV 782 fl and MCH 263 pg.
Parasite invasion of RBCs In 80% of experiments the interval from blood sampling to the start of culture was less than 2 hours. In 6 samples the experiments were conducted immediately and repeated 24 hours later. The results were similar in the paired comparison. In parasite cultures, containing an equal number of normal and abnormal hemoglobin RBCs (HRBCs), the abnormal RBCs were readily distinguished from the normal RBCs (NRBCs) by positive fluorescence staining of the blood group antigens as shown in Figure 1.
There were no major differences between SR or SI values in static or
agitated cultures either for normal AA (mean [95% CI]) difference of
SR = In parallel control cultures (n = 34), there were no differences in
the SR values of 50:50 mixtures of normal hemoglobin RBCs (HbAA) of
blood groups A, B, or O (P = .3). For all 34 donors with
HbAA the median (range) SR was 0.88 (0.53-1.4), that is, not
significantly different from 1. Within each slide, the proportion of
parasitized HRBCs (median [range] = 2% [0.1%-9%]) was
significantly lower than the number of parasitized NRBCs (median
[range] = 5.2 [1.2%-16.3%]; P = .01). The median
difference in parasitemia between the HRBC and NRBC counts was 3.2%
(range, 1.9%-12.6%; P = .001) and the median (range)
NRBC/HRBC ratio was 2.94 (0.38-58). The mean (SD) multiplication rates,
from the 1% starting parasitemia in unmixed cultures (n = 10 for
each group) were 3.5 (1.3) in the control cells (AA controls) and 3.5 (2.7) in the AA tested cells. These values were significantly higher
than in the AE cells, 2.6 (1.7) and in the EE cells, 2.8 (1.7)
(P = .03). However, the multiplication rates were
significantly higher in the AA control cells in mixed cultures with
thalassemic cells: 7.8 (4.9) in AA controls versus the AE cells
(n = 20 comparisons) and 5.1 (2.1) in AA controls versus the EE cells
(n = 22 comparisons). This indicated preferential invasion of the
normal cells and was reflected in significantly reduced susceptibility
ratios for the thalassemic cells. The median (range) SR of all the RBCs
with abnormal hemoglobin (n = 109) was significantly lower 0.40 (0.08-0.98) than that of the normal RBCs (P = .01). The
median (range) SR of HbEE RBCs, 0.69 (0.13-0.98), was significantly
higher than that of HbAE RBCs, 0.34 (0.05-0.64); HbH, 0.28 (0.11-0.78);
HbHCS (Constant Spring), 0.3 (0.11-0.8); and
Selectivity indices To determine whether the reduced invasion rates in abnormal hemoglobinopathic RBCs resulted from increased selectivity (a reduced proportion of susceptible RBCs) or a generalized resistance to invasion, we counted the number of RBCs containing more than one parasite and compared these with the expected value from the Poisson distribution to obtain the SI as described above. Because the parasitemia of the HRBCs was lower than in those RBCs with normal hemoglobin, the expected number of multiply invaded RBCs was also lower. To accommodate for systematic counting errors, and thus ensure the coefficient of variation for the counting of multiple invaded RBCs was the same for both normal and abnormal hemoglobin RBCs, more parasitized abnormal RBCs (500 cells) were counted. The median (range) SI of abnormal RBCs, 0.91 (0-20), was significantly higher than that of normal RBCs, 0.47 (0-2.3; P < .001) as shown in Figure 3. When the SI values were compared among the different hemoglobin types, the difference was found to result mainly from the high SI for AE cells. The median (range) SI of HbAE RBCs, 3.85 (1-15), was significantly higher than those of HbH RBCs, 1.15 (0.32-6.25); HbCS, 0.92 (0.34-5); -thalassemia/HbE, 0.9 (0-7);
and HbEE, 0.75 (0.35-0.9) (P .01). There were no associations between SI and MCV or MCH (r = 0.13,
P = .028 and r = 0.12, P = .38,
respectively). The surface areas of the RBCs were calculated from MCV,
but there was no association between surface area and invasion
susceptibility (both SR and SI; P = .175 and
P = .19, respectively).
Abundant epidemiologic evidence suggests that certain genetic
disorders of RBCs have been selected because they confer protection from malaria.21-27 However, it has proved difficult to
show in the laboratory exactly how this protective mechanism operates. Erythrocytes containing sickle cell hemoglobin retard parasite maturation and thus reduce multiplication.28-30 P
falciparum grows slowly in homozygous HbE RBCs, but not in
heterozygous RBCs.7,31 In hereditary ovalocytosis, there
is both increased membrane rigidity and a hostile intraerythrocytic
milieu.32 The increased amounts of hemoglobin F present in
patients with some hemoglobinopathies is also associated with impaired
malaria parasite growth.33-35 Some
studies,36,37 but not others,38 have shown
greatly reduced cytoadherence and rosette formation by In this study, evidence is presented that certain genetic RBC abnormalities, prevalent in Thailand, are associated with reduced parasite invasion when starting parasite densities are high (1%). This reflects the situation on the threshold of developing severe malaria. RBCs from patients with most of the hemoglobinopathies represented in this study are functionally abnormal. The general susceptibility ratios observed in these abnormal cells were lower than those of normal cells suggesting a process affecting all the cells. These dysfunctional cells may not have withstood ex vivo culture conditions as well as their normal counterparts and this may have resulted in membrane changes that led to reduced parasite invasion. Thus, the in vivo relevance of these findings is uncertain. Heterozygote AE cells, although they are microcytic and contain less hemoglobin, are generally considered to be functionally relatively normal, and so the finding that invasion was reduced more in these cells than in homozygous EE cells is surprising and likely to be of clinical relevance. This suggests a membrane abnormality and cannot be related to poor intraerythrocytic growth. Hemoglobin E is common in Southeast Asia. Epidemiologic studies have been divided as to whether hemoglobin E protects from malaria infection9,10 although recent evidence from clinical studies indicates that this hemoglobin type does confer protection from severe malaria.11 Earlier studies were also divided on whether hemoglobin E reduced parasite multiplication.7,31 The multiplication rates observed in this study are not strictly comparable with earlier data for 2 reasons. First, the abnormal cells were mixed with normal cells providing an alternative for merozoite invasion, and second we chose to examine a single cycle and to start at a relatively high parasite count (1%). The earlier studies started at counts approximately 10 times lower and averaged the counts over 2 cycles. This may overestimate considerably the count in the second cycle because multiplication falls as parasite densities rise over 1%. Yet this is the range of parasite counts of greater relevance to severe malaria. Interestingly, multiplication rates in normal (AA) cells were significantly higher when mixed with thalassemic cells compared to mixture with other AA cells. This indicates that merozoite release was unaffected by the type of surrounding RBCs, but that there was preferential invasion of normal cells by the liberated merozoites. The reduction in RBC invasion in HbAE heterozygotes was associated with a 4-fold increase in the selectivity index compared the other hemoglobin types studied and in particular the EE homozygotes. This is a reflection of the proportion of the RBC population that can be invaded and suggests that in heterozygote individuals with AE hemoglobin, only a quarter of the RBC population can be invaded by P falciparum. This was very different from the findings with RBCs with the other hemoglobin types in this study. It would be expected to limit the potential for parasite multiplication and thus attenuate the expansion of the P falciparum malaria infection, particularly at high parasitemias. It may also explain some previous inconsistencies in the literature. If invasion is restricted to only a subpopulation of the RBC population, then parasite densities will be affected only at high values. Multiplication at lower densities, and thus the incidence of malaria, would not be affected greatly, but the heavy parasitemias that are associated with severe malaria would be prevented. This is analogous to the situation with P vivax where invasion is restricted to only 13% of the RBC population (based on RBC age)13 and severe malaria is very rare. Thus, the protection conferred by AE cells may operate against severe rather than uncomplicated malaria. These data suggest an unidentified surface, or membrane difference, in these heterozygote cells. Previous studies showing increased human monocyte phagocytosis of HbAE cells infected with P falciparum also led to a suggestion of a membrane abnormality in these cells.43 Potential factors that reduce the probability of invasion by P falciparum include differences in membrane rigidity and in particular in glycophorin and sialic acid content. It would be of interest to determine whether RBC age is the factor determining invasion in AE cells. This study suggests that the genetics of hemoglobin E may be explained by a balanced polymorphism in which the deleterious effects of the homozygote condition are offset by the protection against high parasitemias and thus severe malaria conferred by the heterozygote.
We would like to thank to Mr Narongchai Tongyoo, Miss Bongkot Soonthornsata, and Miss Mayuree Chimweset for their help in the laboratory. We are very grateful to Sir David Weatherall for his comments and advice.
Submitted October 16, 2001; accepted March 20, 2002.
This work was a part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Nicholas White, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi, Bangkok, Thailand; e-mail: fnnjw{at}diamond.mahidol.ac.th.
1. Molineaux L, Fleming AF, Cornille- Brogger R, Kagen I, Storey J. Abnormal hemoglobins in the Sudan savanna of Nigeria. Ann Trop Med Parasitol. 1979;73:301-310[Medline] [Order article via Infotrieve].
2.
Flint J, Hill AVS, Bowden K, et al.
High frequencies of 3. Oppenheimer SJ, Hill AVS, Gibson FD, Macfarlane SB, Moody JB, Pringle J. The interaction of alpha thalassemia with malaria. Trans R Soc Trop Med Hyg. 1987;81:322-336[CrossRef][Medline] [Order article via Infotrieve]. 4. Weatherall DJ. Common genetic disorders of the red cell and the malaria hypothesis. Ann Trop Med Parasitol. 1987;81:539-548[Medline] [Order article via Infotrieve]. 5. Senok AC, Nelson EAS, Oppenheimer SJ. Thalassemia trait, red blood cell age and oxidant stress: effect on Plasmodium falciparum growth and sensitivity to artemisinin. Trans R Soc Trop Med Hyg. 1997;91:585-589[CrossRef][Medline] [Order article via Infotrieve]. 6. Weatherall DJ. Thalassemia and malaria, revisited. Ann Trop Med Parasitol. 1997;91:885-890[CrossRef][Medline] [Order article via Infotrieve]. 7. Nagel RL, Raventos-Suarez C, Febby ME, Tonowitz H, Sicard D, Labie D. Impairment of the growth of P. falciparum in HbEE erythrocytes. J Clin Invest. 1981;68:303-305[Medline] [Order article via Infotrieve].
8.
Santiyanont R, Wilairat P.
Red cells containing hemoglobin E do not inhibit malaria parasite development in vitro.
Am J Trop Med Hyg.
1981;30:541-543 9. Kruatrachue M, Bhaibulaya M, Klongkamnaunkarn K, Harinasuta C. Haemoglobinopathies and malaria in Thailand. Bull WHO. 1969;40:459-463[Medline] [Order article via Infotrieve]. 10. Flatz G, Pik C, Sundharagiati B. Malaria and haemoglobin E in Thailand. Lancet. 1964;ii:385-387. 11. Hutagalung R, Wilairatana P, Looareesuwan S, et al. Influence of hemoglobin E trait on the severity of falciparum malaria. J Infect Dis. 1999;179:283-286[CrossRef][Medline] [Order article via Infotrieve].
12.
Williams TN, Maitland K, Bennett S, et al.
High incidence of malaria in 13. Simpson J, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ. Red cell selectivity in malaria: a study of multiple infected erythrocytes. Trans R Soc Trop Med Hyg. 1999;93:165-168[CrossRef][Medline] [Order article via Infotrieve]. 14. Chotivanich K, Udomsangpetch R, Simpson J, et al. Parasite multiplication potential and the severity of falciparum malaria. J Infect Dis. 2000;181:1206-1209[CrossRef][Medline] [Order article via Infotrieve].
15.
Fucharoen S, Winichagoon P, Wisedpanichhij R, et al.
Prenatal and postnatal diagnosis of thalassemias and hemoglobinopathies by HPLC.
Clin Chem.
1998;44:740-748 16. Wasi P, Na-Nakorn P, Pootrakul S, et al. Alpha and beta thalassemia in Thailand. Ann N Y Acad Sci. 1969;165:60-82[Medline] [Order article via Infotrieve]. 17. Winichagoon P, Adirojnon P, Wasi P. Levels of haemoglobin H and proportion of red cells with inclusion bodies in the two types of haemoglobin H disease. Br J Haematol. 1980;46:507-510[Medline] [Order article via Infotrieve].
18.
Trager W, Jensen JB.
Human malaria parasites in continuous culture.
Science.
1976;193:673-675 19. Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418-420[CrossRef][Medline] [Order article via Infotrieve]. 20. Rivadeneira EM, Wasserman M, Espinal CT. Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J Parasitol. 1983;30:367-370. 21. Luzzatto L, Nwachuku-Jarrett ES, Reddy S. Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet. 1970;14:319-321. 22. Friedman MJ. Oxidant damage mediates variant red cell resistance to malaria. Nature. 1979;280:245-247[CrossRef][Medline] [Order article via Infotrieve]. 23. Pasvol G, Weatherall DJ. The red cell and the malarial parasite. Br J Haematol. 1980;46:165-170[Medline] [Order article via Infotrieve].
24.
Ifediba TC, Stern A, Ibrahim A, Reider RF.
Plasmodium falciparum in vitro: diminished growth in hemoglobin H disease erythrocytes.
Blood.
1985;65:452-455 25. Luzzi GA, Torii M, Aikawa M, Pasvol G. Unrestricted growth of Plasmodium falciparum in microcytic erythrocytes in iron deficiency and thalassemia. Br J Haematol. 1990;74:519-524[Medline] [Order article via Infotrieve]. 26. Senok AC, Nelson EAS, Yu LM, Tian LP, Oppenheimer SJ. Invasion and growth of Plasmodium falciparum is inhibited in fractionated thalassemia erythrocytes. Trans R Soc Trop Med Hyg. 1997;91:138-143[CrossRef][Medline] [Order article via Infotrieve].
27.
Pattanapanyasat K, Yongvanitchit K, Tongtawe P, et al.
Impairment of Plasmodium falciparum growth in thalassemic red cells: further evidence by using biotin labeling and flow cytometry.
Blood.
1999;93:3116-3119
28.
Friedman MJ.
Erythrocytic mechanism of sickle cell resistance to malaria.
Proc Natl Acad Sci U S A.
1978;75:1994-1997
29.
Friedman MJ, Roth EF, Nagel RL, Trager W.
The role of hemoglobins C, S and NBatl in the inhibition of malaria parasite development in vitro.
Am J Trop Med Hyg.
1979;28:777-780 30. Pasvol G. The interaction between sickle haemoglobin and the malarial parasite Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1980;74:701-705[CrossRef][Medline] [Order article via Infotrieve]. 31. Vernes AJ-M, Heynes JD, Tang DB, Dutoit E, Diggs CL. Decreased growth of Plasmodium falciparum in red cells contain haemoglobin E, a role for oxidative stress, and a sero-epidemiological correlation. Trans R Soc Trop Med Hyg. 1986;80:642-648[CrossRef][Medline] [Order article via Infotrieve]. 32. Bunyaratvej A, Butthep P, Kaewkettong P, Yuthavong Y. Malaria protection in hereditary ovalocytosis: relation to red cell deformability, red cell parameters and degree of ovalocytosis. Southeast Asian J Trop Med Pub Health. 1997;28:38-42[Medline] [Order article via Infotrieve]. 33. Pasvol G, Weatherall DJ, Wilson RJ, Smith DH, Gilles HM. Fetal hemoglobin and malaria. Nature. 1976;1:1269-1270. 34. Pasvol G, Weatherall DJ, Wilson RJ. Effects of fetal hemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature. 1977;270:171-173[CrossRef][Medline] [Order article via Infotrieve].
35.
Bunyaratvej A, Butthep P, Sae-Ung N, Fuchareon S, Yuthavong Y.
Reduced deformability of thalassemic erythrocytes and erythrocytes with abnormal hemoglobins and relation with susceptibility to Plasmodium falciparum invasion.
Blood.
1992;79:2460-2463
36.
Udomsangpetch R, Sueblinvong T, Pattanapanyasat K, Dharmkrong-at A, Webster HK.
Alteration in cytoadherence and rosetting of Plasmodium falciparum-infected thalassemic red blood cells.
Blood.
1993;82:3752-3759
37.
Carlson J, Nash GB, Gabutti V, Al Yaman F, Wahlgren M.
Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation.
Blood.
1994;84:3909-3914
38.
Luzzi GA, Pasvol G.
Cytoadherence of Plasmodium falciparum-infected 39. Bayoumi RA, Abu-Zeid YA, Abdulhadi NH, et al. Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects. Immunol Lett. 1990;25:243-249[CrossRef][Medline] [Order article via Infotrieve].
40.
Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, Weatherall DJ.
Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in 41. Abu-Zeid YA, Theander TG, Abdulhadi NH, et al. Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals. Clin Exp Immunol. 1992;88:112-118[Medline] [Order article via Infotrieve]. 42. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 1997;91:256-262[CrossRef][Medline] [Order article via Infotrieve]. 43. Bunyaratavej A, Butthep P, Yuthavong Y, et al. Increased phagocytosis of Plasmodium falciparum infected erythrocytes with haemoglobin E by peripheral blood monocytes. Acta Haematol. 1986;76:155-158[Medline] [Order article via Infotrieve].
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. D. Mais, R. D. Gulbranson, and D. F. Keren The Range of Hemoglobin A2 in Hemoglobin E Heterozygotes as Determined by Capillary Electrophoresis Am J Clin Pathol, July 1, 2009; 132(1): 34 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Antia, A. Yates, and J. C de Roode The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference Proc R Soc B, June 22, 2008; 275(1641): 1449 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vichinsky Hemoglobin E Syndromes Hematology, January 1, 2007; 2007(1): 79 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Mockenhaupt, J. P. Cramer, L. Hamann, M. S. Stegemann, J. Eckert, N.-R. Oh, R. N. Otchwemah, E. Dietz, S. Ehrhardt, N. W. J. Schroder, et al. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria PNAS, January 3, 2006; 103(1): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tiffert, V. L. Lew, H. Ginsburg, M. Krugliak, L. Croisille, and N. Mohandas The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum Blood, June 15, 2005; 105(12): 4853 - 4860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ayi, F. Turrini, A. Piga, and P. Arese Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait Blood, November 15, 2004; 104(10): 3364 - 3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Frodsham and A. V.S. Hill Genetics of infectious diseases Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R187 - R194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fairhurst, H. Fujioka, K. Hayton, K. F. Collins, and T. E. Wellems Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state Blood, April 15, 2003; 101(8): 3309 - 3315. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||